Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Acta Pharmaceutica Sinica ; (12): 399-404, 2012.
Article in Chinese | WPRIM | ID: wpr-323029

ABSTRACT

To study the effect of Cu2+ and Zn2+ on amyloid-beta peptides (Abeta) aggregation, the morphology, size and cell toxicity of Abeta40 aggregates formed with the metal ions have been observed by the methods including ultraviolet spectroscopy, fluorescence spectroscopy and transmission electron microscopy. The results showed that Cu2+ and Zn2+ can accelerate Abeta40 aggregation, and both changed the morphology and size of Abeta40 aggregates. Zn2+ induced Abeta40 to form fibrous Abeta40 aggregates, while the amorphous and fibrous aggregates were produced by the interaction between Cu2+ and Abeta40. In addition, H2O2 was produced when Abeta40 reduced Cu2+. The relationship between metal ions and Abeta40 aggregates was analyzed, and the function of metal ions in Alzheimer's disease (AD) was illustrated in the research.


Subject(s)
Humans , Amyloid beta-Peptides , Chemistry , Cell Survival , Copper , Chemistry , Toxicity , Dose-Response Relationship, Drug , HeLa Cells , Hydrogen Peroxide , Chemistry , Ions , Chemistry , Microscopy, Electron, Transmission , Peptide Fragments , Chemistry , Spectrometry, Fluorescence , Spectrophotometry, Ultraviolet , Zinc , Chemistry
2.
China Journal of Orthopaedics and Traumatology ; (12): 7-9, 2008.
Article in Chinese | WPRIM | ID: wpr-324060

ABSTRACT

<p><b>OBJECTIVE</b>To explore the feasibility of percutaneous vertebroplasty for the treatment of acute burst thoracolumbar fracture.</p><p><b>METHODS</b>Fifty-eight patients (male 38 and female 20, ranging in age from 38 to 70 years, with an average of 56.8 years) with acute burst thoracolumbar fracture were treated by percutaneous vertebroplasty. The injuried vertebrae were T11 in 3 cases, T12 18 cases, L1 29 cases, L2 5 cases and L3 3 cases. All suited cases were classified into 3 types according to injuried vertebral shapes,type I (safe type 26 cases), type II (risk type 21 cases), and type III (marginal type 11 cases).</p><p><b>RESULTS</b>All the patients were followed up ranging from 1 to 2.5 years (mean 1.6 years). Fifty-three patients could walk in 1 to 3 days after operation. Among 55 patients who obtained complete recovery (CR), 39 patients could do daily works and 16 patients could do houseworks. The CR rate was 95%. Three patients who obtained partial recovery (PR), could live by themselves and felt slight lumbago after movements. The PR rate was 5%.</p><p><b>CONCLUSION</b>Percutaneous vertebroplasty for the treatment of acute burst thoracolumbar fracture is a feasible and effective method even for particular risks.</p>


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Acute Disease , Lumbar Vertebrae , Wounds and Injuries , General Surgery , Radiography , Spinal Fractures , Diagnostic Imaging , General Surgery , Thoracic Vertebrae , Wounds and Injuries , General Surgery , Vertebroplasty , Methods
3.
Chinese Journal of Pediatrics ; (12): 352-356, 2003.
Article in Chinese | WPRIM | ID: wpr-345493

ABSTRACT

<p><b>OBJECTIVE</b>To explore the antibacterial activity of amoxycillin sodium and clavulanate potassium (trade name: Anqi) in vitro and the pharmacoeconomics in the therapy of acute respiratory infection.</p><p><b>METHODS</b>Minimal inhibition concentration (MIC), minimal bactericidal concentration (MBC) and bactericidal curve of amoxycillin sodium and clavulanate potassium against common pathogens were determined and compared with some other same kind of antibiotics without beta-Lactamase inhibitor. Eighty cases diagnosed as respiratory infection were randomly divided into 4 groups: group 1 was treated with i.v. Anqi; group 2 was treated with i.v. Anqi and oral consecutive strategy; group 3 was treated with iv ampicillin and sulbactam; group 4 was treated with i.v. cefuroxime. The clinical therapeutic effects were observed and cost-effectiveness analyzed.</p><p><b>RESULTS</b>In terms of MIC, MBC and bactericidal curve of 135 bacterial strains, Anqi was superior to the other same-kind antibiotics without beta-lactamase inhibitor, this effect was especially obvious on Klebsiella pneumoniae and Escherichia coli which can produce extended spectrum beta-lactamases (ESBLs). The cost-effectiveness of the consecutive therapy group was the best.</p><p><b>CONCLUSION</b>Anqi has a wide antimicrobial spectrum and strong effect on the bacteria producing ESBLs, the consecutive therapy strategy should be clinically recommended.</p>


Subject(s)
Child , Child, Preschool , Female , Humans , Infant , Male , Amoxicillin , Pharmacology , Therapeutic Uses , Anti-Bacterial Agents , Pharmacology , Therapeutic Uses , Bacteria , Clavulanic Acid , Pharmacology , Therapeutic Uses , Dose-Response Relationship, Drug , Drug Therapy, Combination , Therapeutic Uses , Microbial Sensitivity Tests , Respirovirus Infections , Drug Therapy , Economics , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL